Showing results (1-10 of 2,511) with videos related to
Sort By:
Pageof 252
Rinsho Byori. the Japanese Journal of Clinical Pathology|September 1, 1995
[Changes in plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) by the interferon treatment for chronic hepatitis C]T Hayashi, S Ro, A Kamogawa, et al.Rinsho Byori. the Japanese Journal of Clinical Pathology|January 1, 1990
[Qualitative analysis of tissue plasminogen activator in plasma obtained from various liver diseases by gel filtration and affinity chromatography]M Takatori, A Kamogawa, S Iwabuchi, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|March 1, 1990
[Effects on blood coagulation-fibrinolytic system after transcatheter hepatic arterial therapy in cases of hepatocellular carcinoma analyzed by plasma levels of plasmin-alpha 2-PI complex, D dimer and thrombin-ATIII complex]A Mizuguchi, S Iwabuchi, N Moriyama, et al.Liver|August 26, 1998
Plasma from patients with cirrhosis increases tissue plasminogen activator release from vascular endothelial cells in vitroT Hayashi, A Kamogawa, S Ro, et al.Rinsho Byori. the Japanese Journal of Clinical Pathology|February 1, 1992
[Influence of aging and circadian fluctuation of fibrinolytic factors to the responses of these factors during venous occlusion test in healthy subjects]F Motohashi, Y Masui, A Kamogawa, et al.Biochimica Et Biophysica Acta|October 22, 1975
Photooxidation of alpha-glucan phosphorylases from rabbit muscle and potato tubersA Kamogawa, T FukuiInternal Medicine (Tokyo, Japan)|November 7, 2000
Congenital hepatic fibrosis with fatal cholestatic liver damageM Takatori, S Iwabuchi, T Hayashi, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|April 29, 1998
[The clinical significance of plasma tissue plasminogen activator (t-PA) levels in severe acute or fulminant hepatitis]T Hayashi, Y Kobayashi, K Yamaguchi, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|April 29, 1998
[Drug delivery system in cardiovascular drugs]F Miyake, A Kamogawa, M SakakibaraNihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2001
[Dynamics of serum HCV RNA levels during IFN therapy in patients with chronic hepatitis C for prediction of outcome of IFN therapy and beneficial dosing]S Iwabuchi, K TakatsukaPageof 252